# Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer

> **NCT07675876** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Carcinex Inc** · enrollment: 10 (estimated)

## Conditions studied

- Locally Advanced Non-Small Cell Lung Cancer
- Lung Adenocarcinoma

## Interventions

- **DRUG:** Cromolyn Sodium

## Key facts

- **NCT ID:** NCT07675876
- **Lead sponsor:** Carcinex Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-06
- **Final completion:** 2027-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675876, "Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*